Evidence map›Paper›PMID 27498840›Full record

ArticleInternational journal of oncology2016

SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.

Jerusha Boyineni, Smita Tanpure, Manu Gnanamony, Reuben Antony, Karen S Fernández, Julian Lin, David Pinson, Christopher S Gondi

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jerusha BoyineniDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Smita TanpureDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Manu GnanamonyDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Reuben AntonyDepartment of Pediatrics, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Karen S FernándezDepartment of Pediatrics, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Julian LinDepartment of Neurosurgery, University of Illinois College of Medicine, Peoria, IL 61605, USA.
David PinsonDepartment of Pathology, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Christopher S GondiDepartment of Internal Medicine, University of Illinois College of Medicine, Peoria, IL 61605, USA.
Illinois College · USUniversity of Illinois Urbana-Champaign · US

Funding

Combination therapy to inhibit neuroblastoma growthR01CA147792 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GONDI, CHRISTOPHER SUMEET BABU · 2010 to 2014
$1.6M
NCI NIH HHS R01 CA147792
6 · The paper itself

Abstract

Neuroblastoma (NB) is the most common extra-cranial solid tumor in children and despite aggressive therapy survival rates remain low. One of the contributing factors for low survival rates is aggressive tumor angiogenesis, which is known to increase due to radiation, one of the standard therapies for neuroblastoma. Therefore, targeting tumor angiogenesis can be a viable add-on therapy for the treatment of neuroblastomas. In the present study, we demonstrate that overexpression of secreted protein acidic and rich in cysteine (SPARC) suppresses radiation induced angiogenesis in SK-N‑BE(2) and NB1691 neuroblastoma cells. We observed that overexpression of SPARC in SK-N-BE(2) and NB1691 cells reduced radiation induced angiogenesis in an in vivo mouse dorsal skin model and an ex vivo chicken CAM (chorioallantoic-membrane) model and also reduced tumor size in subcutaneous mouse tumor models of NB. We also observed that SPARC overexpression reduces VEGF-A expression, in SK-N-BE(2) and NB1691 NB cells via miR-410, a VEGF-A targeting microRNA. SPARC overexpression alone or in combination with miR-410 and radiation was shown to be effective at reducing angiogenesis. Moreover, addition of miR-410 inhibitors reversed SPARC mediated inhibition of VEGF-A in NB1691 cells but not in SK-N-BE(2) NB cells. In conclusion, the present study demonstrates that the overexpression of SPARC in combination with radiation reduced tumor angiogenesis by downregulating VEGF-A via miR-410.

Indexed as

Angiogenesis InhibitorsAnimalsCell Line, TumorGene Expression Regulation, NeoplasticGenetic TherapyHumansMiceMicroRNAsNeoplasm TransplantationNeovascularization, PathologicNeuroblastomaOsteonectinRadiotherapyVascular Endothelial Growth Factor AXenograft Model Antitumor AssaysAngiogenesis InhibitorsMicroRNAsMIRN410 microRNA, humanOsteonectinSPARC protein, humanVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID27498840
PMCPMC5021251
OpenAlexW2492009533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.